Summary
Prednisolone absorption and bioavailability of 10 mg enteric-coated (EC) and plain (uncoated) tablets were investigated after fasting and heavy meals (EC only) consumed to satiety in normal healthy volunteers. The same volunteers had also received 16 mg of prednisolone intravenously.
In fasted subjects, the absolute bioavailability fraction, as normalised for intravenous doses, of prednisolone from plain tablets was 1.055 and from EC tablets was 0.996. The peak concentrations after plain and EC tablets were 309 and 249 ng/ml attained at 0.98 and 5.14 h, respectively. The means plasma elimination half-lives following the plain, EC tablets and intravenous administration in fasting conditions were 3.73, 3.89 and 3.78 h, respectively.
Food interfered with both the absorption and the pharmacokinetics of prednisolone after EC tablets resulting in variability in its plasma levels. In some cases absorption of prednisolone was delayed for 12 h and remained at a measurable level for 24 h. In other cases, a normal absorption pattern was observed.
This inter- and intrasubject variability of the effect of food appears to be related to its quantity, constituents and also the subjects physiological characteristics. It is concluded that enteric-coated prednisolone tablets should be administered at least 2 h between meals. However, for more predictable corticosteroid absorption (perhaps thus avoiding the therapeutic failure), plain prednisolone tablets are preferable.
References
Schneller GH (1969) Hazard of therapeutic nonequivalency of drug products. J Am Pharm Ass 9: 455–459
Healey LA (1973) Generic equivalents. Arthritis Rheum 16: 775
Levy G, Hall NA, Nelson E (1964) Studies on inactive prednisone tablets USP XVI. Am J Hosp Pharm 21: 402
Campagna FA, Cureton G, Mirigian RA, Nelson E (1963) Inactive prednisone tablets USP. XVI. J Pharm Sci 52: 605–606
Al-Habet S, Kinsella HC, Rogers HJ, Trounce JR (1980) Malabsorption of prednisolone from enteric-coated tablets after ileostomy. Br Med J 281: 843–844
Olivesi A (1985) Non-absorption of enteric-coated prednisolone. Therapie 40: 5–7
Fernando ON, Moorhead J (1979) Absorption of enteric-coated prednisolone. Br Med 1: 1795–1796
Henderson RG, Wheatley T, English J, Chakraborty J, Marks V (1979) Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone. Br Med J 1: 1534–1536
Mant TGK (1979) Investigation of a case of prednisolone malabsorption. Postgrad Med J 55: 421–422
Hulme B, James VHT, Rault R (1975) Absorption of enteric and non-enteric coated prednisolone tablets. Br J Clin Pharmacol 2: 317–320
Lee DAH, Taylor GM, Walker JG, James VHT (1979) The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets. Br J Clin Pharmacol 7: 523–528
Morrison PJ, Bradbrook ID, Rogers HJ (1977) Plasma prednisolone levels from enteric and non-enteric-coated tablets estimated by an original technique. Br J Clin Pharmacol 4: 597–603
Wilson CG, May CS, Paterson JW (1977) Plasma prednisolone levels after administration in plain and enteric-coated tablets. Br J Clin Pharmacol 4: 703–704
Leclercq R, Copinschi G (1974) Pattern of plasma levels of prednisolone after oral administration in man. J Pharmacokinet Biopharm 2: 175–187
Tembo AV, Sakmar E, Hallmark MR, Weidler DJ, Wagner JG (1976) Effect of food on the bioavailability of prednisone. J Clin Pharmacol 16: 620–624
Uribe M, Schalm SW, Summerskill WHJ, Go VLW (1976) Effect of liquid diet on serum protein binding and prednisolone concentrations after oral prednisone. Gastroenterology 71: 362–364
Al-Habet S, Rogers HJ (1980) Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol 10: 503–508
Al-Habet SMH, McAllister WAC, Collins JV, Rogers HJ (1981) Comparison of radioimmunoassay and thin layer chromatographic assay methods for estimation of plasma prednisolone concentrations. J Pharmacol Methods 6: 137–142
Al-Habet SMH, Rogers HJ (1989) Two chromatographic methods for the determination of corticosteroids in human biological fluids: pharmacokinetic applications. J Pharm Sci 78: 660–666
Al-Habet SMH, Rogers HJ (1989) Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 27: 285–290
Melander A, Laka D, McLean A (1988) Influence of food on the presystemic metabolism of drugs. Pharmacol Ther 38: 253–267
Yang CS, Yoo JH (1988) Dietary effects on drug metabolism by the mixed-function oxidase system. Pharmacol Ther 38: 53–72
Welling PG (1986) Pharmacokinetic processes and mathematics, chapters 5 and 6. Pub ACS Monograph 185, American Chemical Society, Washington DC, pp 45–76
Johansson O, Lindberg T, Melander A, Wåhlin-Boll E (1985) Different effects of different nutrients on theophylline absorption in man. Drug Nutr Interact 3: 205–211
Hathcock TN (1985) Metabolic mechanism of drug-nutrient interactions. Fed Proc 44: 124–129
Al-Habet SM, Rogers HJ (1985) Prednisolone elimination in human saliva. Int J Clin Pharmacol Ther Toxicol 23: 485–487
Al-Habet SMH, Rogers HJ (1989) Urinary excretion of prednisolone following intravenous administration in human. J Clin Pharmacol 29: (October)
Author information
Authors and Affiliations
Additional information
Part of this study was presented at the joint annual meeting of the American College of Clinical Pharmacology (ACCP) and the American Association of pharmaceutical Scientists (AAPS), Orlando, Florida, (J Clin Pharmacol 28 (1988): 923–924)
Deceased
Rights and permissions
About this article
Cite this article
Al-Habet, S.M.H., Rogers, H.J. Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets. Eur J Clin Pharmacol 37, 423–426 (1989). https://doi.org/10.1007/BF00558515
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558515